Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoietic and Lymphatic System Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06817889
What this trial is testing

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmAutoimmune DiseaseRespiratory Syncytial Virus Infection
Fred Hutchinson Cancer Center 60
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Post-approval studies (Phase 4)UnknownNCT05545202
What this trial is testing

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Who this might be right for
Malignant LymphomaMultiple Myeloma
Pharmacosmos A/S 150
Not applicableLooking for participantsNCT06897137
What this trial is testing

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

Who this might be right for
Malignant Solid NeoplasmHematopoietic NeoplasmsLymphatic System Neoplasm
Wake Forest University Health Sciences 3,000
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Not applicableLooking for participantsNCT00991094
What this trial is testing

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Who this might be right for
Breast CarcinomaEsophageal CarcinomaGenitourinary System Carcinoma+6 more
M.D. Anderson Cancer Center 5,000
Testing effectiveness (Phase 2)Study completedNCT00007995
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Herbert Irving Comprehensive Cancer Center 75
Not applicableStudy completedNCT03200977
What this trial is testing

Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab

Who this might be right for
Lymphoma
Bristol-Myers Squibb 95
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Ended earlyNCT01050946
What this trial is testing

Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit

Who this might be right for
Leukemia, Lymphocytic, AcuteLeukemia, Lymphocytic, ChronicLeukemia, Myelocytic, Acute+3 more
Medical College of Wisconsin 1
Not applicableStudy completedNCT03198754
What this trial is testing

Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue

Who this might be right for
Cancer-related Problem/ConditionDepressionCircadian Rhythm Disorders
Icahn School of Medicine at Mount Sinai 73
Early research (Phase 1)WithdrawnNCT04464889
What this trial is testing

HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMyelodysplastic Syndromes+5 more
Medigene AG
Early research (Phase 1)Study completedNCT00186589
What this trial is testing

90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL

Who this might be right for
Lymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)
Stanford University 30
Testing effectiveness (Phase 2)Study completedNCT04716075
What this trial is testing

Acalabrutinib in CLL and MCL Patients Subjected to Allogeneic Hematopoietic Stem Cell Transplantation (alloSCT)

Who this might be right for
Chronic Lymphocytic LeukemiaChronic Graft-versus-host-diseaseMantle Cell Lymphoma+2 more
Polish Lymphoma Research Group 29
Testing effectiveness (Phase 2)Study completedNCT00448357
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
UNC Lineberger Comprehensive Cancer Center 54
Not applicableUnknownNCT03462095
What this trial is testing

De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
National Research Center for Hematology, Russia 350
Next Page